Omthera seeks 'best in class' status for prescription omega-3 product Epanova
10 January 2012
Pial Ganguli
Please Login to read the full article.
10 January 2012
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- Phase III data EVOLVE-ing nicely for Omthera's Epanova
- Amarin secures US formulation patent for fish oil pill, fueling more talk on a pharma deal
- Amarin rises on US FDA acceptance of fish oil pill NDA
- Competition looms for Mochida as Takeda files ProNova's omega-3 product in Japan
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
